DexCom (DXCM) Misses Q3 EPS by 1c, Revenue Beats

DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69 million versus the consensus estimate of $60.2 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)
• Citi sees Birkenstock EPS beat, guidance lift on FX and lower share count